Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: John M. Gelnieau who wrote (20780)	4/19/1999 12:37:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

$$$$$$$******IMPORTANT NEWS******$$$$$$$$$ Abstracts are now available for May's AUA meeting. Here are a few links: Regarding safety of MUSE auanet.org Regarding Vivus' involvement with gene therapy: auanet.org auanet.org This could be something big in the future for Vivus since they have the transurethral delivery patent (note the name P. Doherty--I believe he used to work for Vivus as a researcher): auanet.org Involving the combination of Viagra AND MUSE when a patient failed on either alone: auanet.org Well I didn't search them all but the shorts are going to be in for a BIG surprise if Vivus IR can make a point of MAKING COMPANY PRESS RELEASES AFTER EACH ONE OF THESE IMPORTANT FACETS OF VIVUS R&D ARE PRESENTED AT THE AUA MEETING IN MAY!!!! THAT'S RIGHT NINA. YOU PREPARE THE PRESS RELEASE BEFORE THE DAY THAT EACH IMPORTANT PRESENTATION IS MADE AND THEN GUESS WHAT??? THAT'S RIGHT YOU MAKE THE PRESS RELEASE ON THE SAME DAY THAT THE LECTURE IS GIVEN. IN FACT YOU MAKE THE PRESS RELEASE IMMEDIATELY AFTER THE LECTURE IS PRESENTED. THIS IS WHAT WE CALL EFFECTIVE IR/PR.